GTN Infusion Dosing in Left Ventricular Failure
For a 25 mg GTN in 50 mL normal saline solution (concentration = 500 mcg/mL), start the infusion pump at 1.2–2.4 mL/hour to deliver the recommended initial dose of 10–20 mcg/min for acute heart failure, then titrate upward by 5–10 mcg/min (0.6–1.2 mL/hour increments) every 3–5 minutes based on blood pressure response.
Calculation and Initial Setup
Your prepared solution contains:
- Concentration: 25 mg ÷ 50 mL = 500 mcg/mL
To achieve the guideline-recommended starting dose 1, 2, 1:
- 10 mcg/min = 1.2 mL/hour
- 20 mcg/min = 2.4 mL/hour
Dosing Algorithm for LVF
Blood Pressure-Based Approach
If SBP >110 mmHg (optimal scenario) 1, 2, 1:
- Start at 10–20 mcg/min (1.2–2.4 mL/hour)
- Increase by 5–10 mcg/min (0.6–1.2 mL/hour) every 3–5 minutes
- Titrate to symptom relief and blood pressure tolerance
- Maximum typical dose: up to 200 mcg/min (24 mL/hour with your concentration)
If SBP 90–110 mmHg (use with caution) 1, 2, 1:
- Start at lower end: 10 mcg/min (1.2 mL/hour)
- Titrate more slowly with frequent BP monitoring
- Consider arterial line for continuous monitoring if borderline pressures 1
If SBP <90 mmHg (contraindication) 1, 2, 1:
- Do NOT administer GTN as it may reduce central organ perfusion
- Consider inotropic support instead
Titration Strategy
The ESC guidelines provide clear titration parameters 1, 2, 1:
- Monitor BP every 3–5 minutes during titration
- Increase dose incrementally:
- Add 5–10 mcg/min (0.6–1.2 mL/hour) every 3–5 minutes
- Continue until symptoms improve or BP drops excessively
- Target endpoints:
- Relief of dyspnea and pulmonary congestion
- Maintain SBP >90–100 mmHg
- Avoid symptomatic hypotension
Critical Safety Considerations
Absolute Contraindications
- SBP <90 mmHg 1, 2, 1
- Severe aortic stenosis (risk of marked hypotension) 1, 2, 1
- Congestive heart failure with chronic renal disease (observe cautiously for volume overload) 3
Common Pitfalls to Avoid
Large cannula delay: If using a large-bore IV cannula (e.g., 16G gray), drug delivery is delayed significantly at low infusion rates. A gray cannula requires >6 minutes for drug to reach the patient at 1 mL/hour versus 1.5 minutes with a smaller pink cannula 4. Solution: Use higher initial infusion rates (2–4 mL/hour) with large cannulas, then adjust downward.
Tachyphylaxis: Tolerance develops after 24–48 hours of continuous infusion 1, 2, 1, necessitating dose escalation or drug holidays.
Headache: Frequently reported but usually transient 1, 2, 1.
Hemodynamic Effects
GTN acts predominantly as a venodilator at lower doses (reducing preload) and provides balanced arterial and venous dilation at higher doses (reducing both preload and afterload) 1, 2, 1. At infusion rates <30 mcg/min, venodilation predominates; at higher rates, arterial effects become significant 5.
The drug relieves pulmonary congestion without compromising stroke volume or increasing myocardial oxygen demand in acute heart failure, particularly beneficial in patients with acute coronary syndromes 1, 2, 1.
Monitoring Requirements
- Frequent non-invasive BP measurements (every 3–5 minutes during titration) 1, 2, 1
- Arterial line not routinely required but facilitates titration in borderline pressures 1, 2, 1
- Continuous assessment of symptoms (dyspnea, orthopnea)
- Heart rate and rhythm monitoring
Practical Summary Table
| Pump Rate (mL/hr) | Dose (mcg/min) | Clinical Use |
|---|---|---|
| 1.2 | 10 | Starting dose (SBP 90–110) |
| 2.4 | 20 | Starting dose (SBP >110) |
| 3.6 | 30 | Low-moderate dose |
| 6.0 | 50 | Moderate dose |
| 12.0 | 100 | High dose |
| 24.0 | 200 | Maximum typical dose |
Remember: Your specific concentration (500 mcg/mL) requires these calculations. Standard pre-mixed GTN solutions may have different concentrations requiring different pump rates.